Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Clinical Study to Assess the Efficacy of NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia

NCT04315987 is registered in ClinicalTrials.gov with Azidus Brasil as lead sponsor.

NCT NCT04315987
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04315987 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Clinical Study to Assess the Efficacy of NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia
Lead sponsor
Azidus Brasil
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2020
Completion date
February 28, 2021
Enrollment
90 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pneumonia